![](/img/cover-not-exists.png)
Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery
David M. Ansley, Koen Raedschelders, David D.Y. Chen, Peter T. ChoiVolume:
30
Year:
2009
Language:
english
Pages:
386
DOI:
10.1016/j.cct.2009.03.004
File:
PDF, 249 KB
english, 2009